ai-based-molecular-profiling | Media Room

Press Release May 28, 2024

Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab

LungOI Is Among The First AI-based Tests To Receive a Medicare Payment Rate.

Press Release Feb 12, 2024

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra

ImageneOI is the first NSCLC genomic profiling AI tool on the Sectra Amplifier Marketplace.

Press Release Sep 6, 2023

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling

Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.

Press Release Aug 15, 2023

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care

Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence.

Press Release Aug 11, 2023

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Press Release Jul 31, 2023

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board

Visionaries and Experts, Each Having Played a Historical Role in Advancing Precision Oncology Into Current Clinical Practice

Press Release Jul 26, 2023

Imagene's AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients